Esposito R, Izzo R, Galderisi M, De Marco M, Stabile E, Esposito G, Trimarco V, Rozza F, De Luca N, de Simone G
Hypertension Research Center (CIRIAPA), Federico II University Hospital, Naples, Italy.
Department of Translational Medical Science, Federico II University Hospital, Naples, Italy.
J Hum Hypertens. 2016 Jun;30(6):392-6. doi: 10.1038/jhh.2015.91. Epub 2015 Sep 10.
Little is known about the potential progression of hypertensive patients towards isolated systolic hypertension (ISH) and about the phenotypes associated with the development of this condition. Aim of this study was to detect predictors of evolution towards ISH in patients with initial systolic-diastolic hypertension. We selected 7801 hypertensive patients free of prevalent cardiovascular (CV) diseases or severe chronic kidney disease and with at least 6-month follow-up from the Campania Salute Network. During 55±44 months of follow-up, incidence of ISH was 21%. Patients with ISH at the follow-up were significantly older (P<0.0001), had longer duration of hypertension, higher prevalence of diabetes and were more likely to be women (all P<0.0001). They exhibited higher baseline left ventricular mass index (LVMi), arterial stiffness (pulse pressure/stroke index), relative wall thickness (RWT) and carotid intima-media thickness (IMT; all P<0.001). Independent predictors of incident ISH were older age (odds ratio (OR)=1.14/5 years), female gender (OR=1.30), higher baseline systolic blood pressure (OR=1.03/5 mm Hg), lower diastolic blood pressure (OR=0.89/5 mm Hg), longer duration of hypertension (OR=1.08/5 months), higher LVMi (OR=1.02/5 g m(-2.7)), arterial stiffness (OR=2.01), RWT (OR=1.02), IMT (OR=1.19 mm(-1); all P<0.0001), independently of antihypertensive treatment, obesity, diabetes and fasting glucose (P>0.05). Our findings suggest that ISH is a sign of aggravation of the atherosclerotic disease already evident by the target organ damage. Great efforts should be paid to prevent this evolution and prompt aggressive therapy for arterial hypertension should be issued before the onset of target organ damage, to reduce global CV risk.
关于高血压患者向单纯收缩期高血压(ISH)进展的潜在情况以及与该病症发展相关的表型,人们所知甚少。本研究的目的是检测初始收缩期 - 舒张期高血压患者向ISH进展的预测因素。我们从坎帕尼亚健康网络中选取了7801例无心血管(CV)疾病或严重慢性肾病且至少有6个月随访的高血压患者。在55±44个月的随访期间,ISH的发生率为21%。随访时患有ISH的患者年龄显著更大(P<0.0001),高血压病程更长,糖尿病患病率更高,且更可能为女性(所有P<0.0001)。他们表现出更高的基线左心室质量指数(LVMi)、动脉僵硬度(脉压/卒中指数)、相对壁厚度(RWT)和颈动脉内膜中层厚度(IMT;所有P<0.001)。ISH发生的独立预测因素为年龄较大(比值比(OR)=1.14/5岁)、女性性别(OR=1.30)、更高的基线收缩压(OR=1.03/5 mmHg)、更低的舒张压(OR=0.89/5 mmHg)、更长的高血压病程(OR=1.08/5个月)、更高的LVMi(OR=1.02/5 g m(-2.7))、动脉僵硬度(OR=2.01)、RWT(OR=1.02)、IMT(OR=1.19 mm(-1);所有P<0.0001),独立于降压治疗、肥胖、糖尿病和空腹血糖(P>0.05)。我们的研究结果表明,ISH是动脉粥样硬化疾病加重的一个迹象,这在靶器官损害中已很明显。应付出巨大努力来预防这种进展,并且在靶器官损害发生之前就应开展积极的动脉高血压治疗,以降低总体心血管风险。